InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,272.00
(
-0.32%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
-0.25%
)
Bitcoin
63,193.67
(
0.39%
)
Post# of 10489
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Euripides90

Send PM Follow Ignore
Followers 139
Posts 5289
Boards Moderated 0
Alias Born 03/01/2013

Euripides90

Re: None

Tuesday, 11/18/2014 8:33:56 AM

Tuesday, November 18, 2014 8:33:56 AM

Post# of 10489
Up almost 4% PM, more news on DJN which receives wide attention:

Latest News Headlines for Galena Biopharma Inc
Galena Biopharma: Gale-401 Releases The Active Ingredient More Slowly Over Time Than Currently Marketed Versions Of This Drug, And Is Therefore Absorbed More Slowly Into The Bloodstream >GALE Tuesday 11/18/2014 07:10 AM ET - Dow Jones News

Dow Jones News has only provided a headline at this time.
Galena Biopharma: Gale-401 Is Galena's New Formulation Of Anagrelide >GALE Tuesday 11/18/2014 07:09 AM ET - Dow Jones News

Dow Jones News has only provided a headline at this time.
Galena Biopharma: Phase 2 Study Also To Assess Safety And Tolerability of Gale-401, And To Measure Plasma Concentrations Of Anagrelide >GALE Tuesday 11/18/2014 07:09 AM ET - Dow Jones News
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up